At the World Biomaterials Congress, May 28 till June 1, DSM will introduce an important expansion of its high-performance Dyneema Purity® polyethylene fiber portfolio that is targeted to provide increased lifetime and 25 percent greater strength than the original product. This new material, Dyneema Purity® UG, was developed specifically to meet the need for strong, stable orthopedic implants that provide consistent performance over a longer term. DSM is investing significant development resources to tailor Dyneema Purity® grades to specific medical and surgical requirements and support the medical device companies to improve patient outcomes. Through materials innovation and ongoing collaboration with medical device companies, DSM is committed to developing new solutions that increase and extend the performance of implants.

Dyneema Purity® UG grade adds increased creep resistance and enhanced strength to the benefits of the original Dyneema Purity® SGX. It is available in 110, 220, and 440 dtex.

The new product grade provides better creep resistance to support the development of implants that retain their performance for a longer period of time. Further, a 25 percent boost in material strength can help ensure performance of the implant even under more demanding conditions.

Like all Dyneema Purity® grades, the new line delivers the world’s strongest fiber, pliability, smoothness, a low coefficient of friction, and fatigue resistance. The product has been fully and successfully tested according to ISO standards for genotoxicity, cytotoxicity, sensitization/irritation, hemocompatibility, pyrogenicity, and mutagenicity.

“New minimally invasive surgical techniques combined with the active lifestyles of many patients are driving the need for orthopedic implants and other devices that can withstand significant stresses over extended periods,” said Carina Snijder, business manager medical for DSM Dyneema.

“DSM is playing an important role in developing and improving advanced materials for the changing needs of the medical device industry. Building on our original success with Dyneema Purity® we are diversifying this product family to target specialized requirements. Through continuous innovation, DSM is focused on developing innovative biomedical materials to support the medical device industry and improving quality of life for patients.”